Does age of onset of asthma influence the effect of cigarette smoking on lung function? by Thomson, Neil C.
 
 
 
 
 
Thomson, N. C. (2016) Does age of onset of asthma influence the effect of cigarette 
smoking on lung function? American Journal of Respiratory and Critical Care 
Medicine, 194(3), pp. 249-250. 
 
 
There may be differences between this version and the published version. You are 
advised to consult the publisher’s version if you wish to cite from it. 
 
 
http://eprints.gla.ac.uk/122620/ 
     
 
 
 
 
 
 
Deposited on: 29 August 2016 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
Editorial AJRCCM 
1 
 
 
Does age of onset of asthma influence the effect of cigarette smoking 
on lung function? 
 
 
Neil C Thomson MD, FRCP, FERS 
 
 
Institute of Infection, Immunity & Inflammation,  
University of Glasgow, Glasgow, UK 
 
 
Corresponding author 
Professor Neil C Thomson, Institute of Infection, Immunity & Inflammation, University of 
Glasgow, Glasgow, G12 OYN, UK Telephone: 44-141-211-1673. Fax: 44-141-211-3464   
E- mail: neil.thomson@glasgow.ac.uk 
 
 
Word count:    1003 words  
 
  
Editorial AJRCCM 
2 
 
Worldwide prevalence of cigarette smoking in asthma ranges from 9% to 35% (1, 2).  In the 
United States, about 21% of people with asthma smoke compared to 17% of the general 
population (3). Adverse effects of cigarette smoking in asthma include worse symptoms, 
increased chronic mucus hypersecretion and more exacerbations as well as an impaired 
therapeutic response to corticosteroids compared to never-smokers with asthma (1, 4, 5).  Co-
morbidities occur more frequently in people with asthma who smoke with higher rates of 
cardiovascular disease, pneumonia and lung cancer (4). Lung function is reduced (1, 4, 6) and a 
greater proportion of smokers with asthma develop persistent airflow obstruction. Potential 
pathways for the development of persistent airflow obstruction in asthma include sub-maximal 
lung growth and airway remodelling in childhood and/or accelerated rate of decline in lung 
function in adulthood. Asthma in childhood, particularly in those with severe disease, is a risk 
factor for impaired lung function in adulthood  (7, 8). Several longitudinal population-based 
studies report accelerated decline in lung function in adults with asthma, particularly among 
cigarette smokers (9-12). Little is known however, about the effects of cigarette smoking on 
lung function in adulthood among people with childhood-onset persistent asthma, in particular, 
whether airway caliber is reduced by the effects of asthma in childhood and by the additional 
or synergistic effects of cigarette smoking in adulthood. 
 
In this issue of the Journal, Hancox and colleagues (13) report the results of an important study 
that investigated the influence of childhood asthma and cigarette smoking on the development 
of airflow obstruction in adulthood using data from the Dunedin Multidisciplinary Health and 
Development Study. The study recruited 1037 individuals born in 1972/73 and monitored 
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health and behavior outcomes at regular intervals up until the age of 38 years. Information 
obtained included the diagnosis of asthma based on parental-reported or self-reported data, 
pre-and post-bronchodilator spirometric measurements (FEV1/FVC ratios, FEV1, FVC) at ages 18, 
26, 32 and 38 years and cumulative active and second-hand tobacco smoke exposure histories.  
A strength of the Dunedin study is the high rates of participation in the longitudinal 
assessments over a lengthy-period of time. Persistent airflow limitation at age 38 was defined 
using a lower limit of normal set at 5th centile cut-points for post-bronchodilator FEV1/FVC 
ratios among never-smokers with no history of asthma. The population was divided into four 
sub-groups: childhood-onset persistent asthma (n=91), late-onset asthma (n=93), asthma in 
remission (n=85), and non-asthmatic (n=572).  
 
In the Dunedin study (13), active smoking history and childhood-onset asthma were both 
associated with reduced FEV1/FVC ratios at 38 years of age. Of particular interest, a history of 
cigarette smoking was not associated with lower FEV1/FVC ratios in the group with childhood-
onset persistent asthma unlike the other sub-groups with late-onset asthma, asthma in 
remission or non-asthmatics, in whom cumulative smoking history was associated with lower 
FEV1/FVC ratios. Approximately one third of participants with childhood-onset asthma had 
persistent airflow obstruction irrespective of a history of cigarette smoking.  The findings were 
similar using GOLD criterion for persistent airflow obstruction (FEV1/FVC ratio <70%).  
Interestingly, the lack of an adverse effect of cigarette smoking on the decline in lung function 
in childhood-onset persistent asthma was contrary to the author’s original hypothesis (13). 
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Although important, the study by Hancox and colleagues (13) has some potential limitations. 
The diagnosis of asthma was based on self-reported data without objective confirmatory tests 
and some participants may have been misdiagnosed. A cut-off age of >13 years of age was used 
to define late-onset asthma, whereas other studies have used a higher cut-off at 18 years or 
older (14). As the pack-years history of 11.5 years at 38 years was relatively low, an interaction 
between cigarette smoking and childhood onset asthma may develop as the cohort progresses 
into later life due to increased exposure to tobacco smoke, particularly as 28.8% of the 
childhood-onset persistent asthma participants are still current smokers. 
  
Despite these limitations, the results from the Dunedin study are of considerable interest. The 
finding that active smoking does not increase the risk of persistent airflow obstruction in young 
adults whose asthma started in childhood is supported by previous research. Children with 
persistent asthma recruited to the Melbourne Asthma Cohort who smoked as adults had a 
similar decline in lung function at 50 years of age as never-smokers with asthma (8). The Tucson 
Epidemiological Study of Airway Obstructive Disease (15) and the European Community 
Respiratory Health Survey (11) found that cigarette smokers with late-onset asthma had an 
increased risk of developing persistent airflow obstruction and a greater decline in lung 
function respectively compared to smokers with early-onset asthma. The Tasmanian 
Longitudinal Health Study, which included participants with both early-onset and late-onset 
asthma, found a synergistic effect on the development of persistent airflow obstruction of 
smoking, atopy and current asthma (12). 
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The study by Hancox and colleagues (13) was not designed to investigate mechanisms for the 
lack of an effect of cigarette smoking on lung function in childhood-onset persistent asthma. 
The variation in susceptibility to the adverse effects of tobacco smoke on lung function 
between people with asthma that first develops in childhood or adulthood is so far 
unexplained. Differences between age-related phenotypes in one or more of the following risk 
factors may be relevant including the effects of early-life events on lung structure, asthma-
induced airway inflammation and remodelling, atopic status, onset and duration of treatment 
with inhaled corticosteroids, environmental exposures including second-hand smoke, genetic 
factors or other processes (5, 11, 12, 14).  
 
In conclusion, Hancox and colleagues (13) study challenges the concept that cigarette smoking 
adversely effects lung function in asthma irrespective of the age of onset. The finding also 
highlights the need to consider age of onset of asthma as a potentially important variable when 
assessing the effects of cigarette smoking on clinical outcomes, airway inflammation and 
therapeutic responses in asthma and the asthma-COPD overlap syndrome. Finally, smoking 
cessation has a central place in management irrespective of the age of onset of asthma due to 
the harmful effects of cigarette smoking on the health of people with asthma. 
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